CRL vs MNTK · rev $2.00B vs P/E 156, rev $100.4M
Charles River Laboratories (CRL) versus Montauk Renewables Inc (MNTK) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Montauk Renewables Inc (MNTK) is a specialty chemicals company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MNTK revenue for 2026-06-30 was $100.4M. Net income was $231.0K. MNTK currently screens at market cap $222.1M and trailing P/E 156.0.
CRL currently screens at market cap $7.78B. MNTK currently screens at market cap $222.1M and trailing P/E 156.0.
Not investment advice. Open the CRL and MNTK stock pages for the full models.
Not investment advice.